This may not be the complete list of references from this article. Staubli M, Studer H. Behandlung der Arrhythmien mit Amiodaron. Schweiz Med Wochenschr. 1981 Mar 28;111(13):460–465. [PubMed]doi:10.1136/bmj.286.6380.1825-aM Koblic...
Cardiac arrhythmias remain a common cause of death and disability. Antiarrhythmic drugs (AADs) and antiarrhythmic agents remain a cornerstone of current ca
Dr. Zipes: Our experience with antiarrhythmic agents in the United States has been limited to a small number of drugs used over a long period, while the European experience is much broader with the availability of many new antiarrhythmic agents. Let us start with a discussion of one of the ...
doi:10.1177/107424849700200101Bramah N. SinghJ CARDIOVASC PHARMACOL THERSingh BN. Class III antiarrhythmic drugs: Simple versus complex molecules for controlling cardiac arrhythmias. J Cardiovasc Pharamcol Therapeut 1997;2:–6.
Antiarrhythmic drugs in cardiac arrest resuscitation: intravenous amiodarone or intravenous lidocaine?BramahNSinghSageJournal of cardiovascular pharmacology and therapeutics
ICD: ANTIARRHYTHMIC DRUGS AND ANTITACHYCAHDIA PACINGdoi:10.1111/j.1540-8159.1993.tb04615.xNoneBlackwell Publishing LtdPacing and Clinical Electrophysiology
Motohatsu FujiwaraThe Japanese Journal of PharmacologySono, K., AKIMOTO,Y., KURAIiASm, K., FVJIWARA,M. Effects of antiarrhythmic drugs on the extraneuronal accumulation of isoprenaline in perfused rat hearts. N S Arch Pharmaco1334, 145-148 (1986)....
Proarrhythmic effects of new Class III antiarrhythmic drugs, MS-551, sematilide, dofetilide in conscious dogsdoi:10.1016/S0021-5198(19)46469-XYasuki AkieCheng NiXue Yi-xueAkiko OzawaKeitaro HashimotoThe Japanese Journal of Pharmacology
A new method for evaluating the effect of antiarrhythmic drugs on atrioventricular nodal conduction.Linkagehelicitymagnetohydrodynamicssolar magnetismElectrophysiological variables were studied in 19 patients before and after one of three commonly used antiarrhythmic agents. The pacing rate at which alternating ...
Novel Therapeutic Targets for Antiarrhythmic Drugs. Edited by GeorgeE. Billman.doi:10.1002/cmdc.201000151AhmedS. MehannaJohn Wiley & Sons, LtdChemMedChem